The "Power Lunch" team looks back on JC Penney's 2013, which involved perhaps the most fascinating billionaire battles of all time.» Read More
Wondering if Carl Icahn is bullish or bearish on stocks right now? Find out!
Once again, activist investor Carl Icahn turns to Fast Money to set the record straight on all the rumors surrounding his wheeling and dealing.
Being an independent studio rather than part of a media conglomerate, isn't helping Lionsgate avoid pink slips. The movie studio announced Friday that it's cutting 45 jobs.
Diabetes drugmaker Amylin Pharmaceuticals is headquartered in San Diego. Like a lot of companies, though, it's incorporated in Delaware. But, if a couple of major shareholders get their way, AMLN could reincorporate in an unlikely state.
Billions in loans were extended to private equity. How deep in the weeds are they? "In many cases they're buried," Icahn tells us in a Web Extra exclusive.
Here’s our Fast Money Final Trade. Instead of stock picks our gang gives you their thoughts on the brave new world that comes after the election.
Ahead of the election, you should know Carl Icahn has a few concerns.
Carl Icahn might be a lot of things, but shy isn’t one of them. If there’s something he doesn’t like, expect to hear about. And there’s something he doesn’t like.
Carl Icahn's recent increased investment in Lions Gate shares isn't the only news resulting from the company's low stock price. On October 10 the stock dipped below $6, triggering a margin call by Merrill Lynch for Vice Chairman Michael Burns, selling 672,000 shares of his stock, 49 percent of his stake in the company, recorded in a Form 4 filed on October 14.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
If there’s one billionaire investor you don’t want to aggravate its Carl Icahn. What makes us say that? He’s aggravated. Really aggravated. Wait till you see what’s got him going.
We couldn’t talk with legendary investor Carl Icahn and not ask about his portfolio. Here’s what’s got his attention these days.
Fed up with the back room wheeling and dealing on Wall Street? Now you can do something about it, thanks to Carl Icahn.
ImClone Chairman Carl Icahn says latest Bristol Myers offer is "absurd!"
I've been under the weather and too lethargic to even blog for a couple days, but nuthin' like a good ol' fashioned corporate war of words to get me goin' again.
"What we’ve really seen over the last three or four years is greed gone wild, and now we’re paying the price for it in a monster hangover..."
Carl Icahn is angry and when the Queens-born billionaire gets angry, he also gets rich. In an exclusive interview find out why companies may be much worse than you think!
Billionaire investor Carl Icahn reported that he had increased his stake in Motorola to 144.1 million shares from 115.6 million shares the prior quarter. Meanwhile, George Soros raised his stake in Wall Street firm Lehman Brothers to 9.5 million shares.
Biotechnology company ImClone Systems, which rebuffed a $60-per-share takeover offer from Bristol-Myers Squibb, said on Thursday it hired JP Morgan Chase as its financialadviser.
Video rental company Blockbuster posted a second quarter loss of $44.7 million, or 23 cents per share, compared to an 18 cent-per-share loss in the year-ago quarter. But, thanks to improved sales the company raised its outlook, predicting a profit of between $21 million and $36 million for the whole year.